Safety and Efficacy Study of FOLFOX4+Panitumumab vs.FOLFIRI+Panitumumab in Subjects WT KRAS Colorectal Cancer and Liver-only Metastases

ABSTRACT: The purpose of the study is to evaluate the efficacy and safety of the combination of Panitumumab with FOLFOX 4 Chemotherapy or Panitumumab with FOLFIRI Chemotherapy in Subjects with Wild- Type KRAS Colorectal Cancer and liver-only Metastases.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms,Colorectal Cancer Metastatic,Pacientes Con Cáncer Colorrectal Con Kras No Mutado Y Metástasis Sólo Hepáticas.

PROVIDER: 2071139 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR